The UK supermarket group ASDA says it intends to take its campaign to get Resale Price Maintenance abolished on over-the-counter medicines to the European Commission. Last October, ASDA cut the prices of a range of vitamin and mineral supplements by up to 20% (Marketletter October 23, 1995).
The Office of Fair Trading then said it would conduct an investigation to ascertain if there had been any material change in circumstances since the 1970 Resale Prices Act abolished RPM on all products except for medicines and books. However, the OFT told the Marketletter last week that "the best date" it could give for publishing the findings of its investigation was mid-September.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze